STEMI (ST ELEVATION MI)
Clinical trials for STEMI (ST ELEVATION MI) explained in plain language.
Never miss a new study
Get alerted when new STEMI (ST ELEVATION MI) trials appear
Sign up with your email to follow new studies for STEMI (ST ELEVATION MI), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to limit heart damage after major attack
Disease control Recruiting nowThis study tests a medicine called Xolatryp in adults who have had a severe heart attack (STEMI) and are getting a procedure to open blocked arteries. Participants receive either a single 6-hour infusion of Xolatryp or a placebo, and their heart health is monitored for 30 days. T…
Matched conditions: STEMI (ST ELEVATION MI)
Phase: PHASE2 • Sponsor: Nyrada Pty Ltd • Aim: Disease control
Last updated Jul 02, 2026 03:00 UTC
-
Heart attack drug aims to save tiny vessels
Disease control Recruiting nowThis study tests whether the drug ranolazine can protect the tiny blood vessels in the heart after a heart attack. One hundred adults who had a major heart attack and have at least one other blocked artery will receive either ranolazine plus standard care or standard care alone. …
Matched conditions: STEMI (ST ELEVATION MI)
Phase: PHASE2, PHASE3 • Sponsor: Federico II University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could dropping aspirin after a heart attack be safer?
Disease control Recruiting nowThis study tests whether taking only the blood thinner ticagrelor (instead of the usual combination of ticagrelor plus aspirin) can reduce bleeding after a heart attack. It involves 2,570 adults who had a heart attack but did not receive stents or bypass surgery. Participants wil…
Matched conditions: STEMI (ST ELEVATION MI)
Phase: PHASE3 • Sponsor: Montreal Heart Institute • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Could a balloon replace stents in young heart attack patients?
Disease control Recruiting nowThis study compares a drug-coated balloon to a standard drug-eluting stent in 496 young adults (ages 18–50) having a heart attack. The balloon delivers medication to open the artery without leaving a permanent implant, which may reduce long-term risks like blood clots and the nee…
Matched conditions: STEMI (ST ELEVATION MI)
Phase: PHASE3 • Sponsor: National Institute of Cardiovascular Diseases, Pakistan • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC